Amplia Therapeutics Limited Stock Price on October 17, 2024
| INNMF Stock | USD 0.06 0 7.41% |
If you're considering investing in Amplia Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Amplia Therapeutics stands at 0.06, as last reported on the 29th of November, with the highest price reaching 0.06 and the lowest price hitting 0.06 during the day. Amplia Therapeutics appears to be out of control, given 3 months investment horizon. Amplia Therapeutics secures Sharpe Ratio (or Efficiency) of 0.049, which signifies that the company had a 0.049% return per unit of risk over the last 3 months. By analyzing Amplia Therapeutics' technical indicators, you can evaluate if the expected return of 0.89% is justified by implied risk. Please makes use of Amplia Therapeutics' Mean Deviation of 9.55, risk adjusted performance of 0.0394, and Downside Deviation of 20.66 to double-check if our risk estimates are consistent with your expectations.
Amplia Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Amplia |
Sharpe Ratio = 0.049
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | INNMF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 18.11 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.89 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Amplia Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amplia Therapeutics by adding it to a well-diversified portfolio.
Related Headline
Geron Headline on 17th of October 2024
Geron Receives New Coverage from Analysts at Scotiabank by thelincolnianonline.com
Scotiabank began coverage on shares of Geron in a report issued on Wednesday morning, MarketBeat.com reports. The firm issued a sector outperform rating and a 6.00 target price on the biopharmaceutical companys stock. Other equities research analysts have also recently issued reports about the company. Leerink Partnrs raised Geron to a
Amplia Therapeutics Valuation on October 17, 2024
It is possible to determine the worth of Amplia Therapeutics on a given historical date. On October 17, 2024 Amplia was worth 0.11 at the beginning of the trading date compared to the closed value of 0.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Amplia Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Amplia Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amplia Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Amplia Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.11 | 0.11 | 0.11 | 0.11 | 10,000 | |
10/17/2024 | 0.11 | 0.11 | 0.11 | 0.11 | 1.00 |
| 0.11 | 0.11 | 0.11 | 0.11 | 1.00 |
| Backtest Amplia Therapeutics | | | Amplia Therapeutics History | | | Amplia Therapeutics Valuation | Previous | Next |
Amplia Therapeutics Trading Date Momentum on October 17, 2024
| On October 18 2024 Amplia Therapeutics Limited was traded for 0.11 at the closing time. The highest daily price throughout the period was 0.11 and the lowest price was 0.11 . There was no trading activity during the period 1.0. Lack of trading volume on 10/18/2024 did not affect price variability. The overall trading delta to current closing price is 25.45% . |
Amplia Therapeutics Fundamentals Correlations and Trends
By evaluating Amplia Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Amplia Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Amplia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Amplia Therapeutics Pink Sheet history
Amplia Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amplia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amplia Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amplia Therapeutics stock prices may prove useful in developing a viable investing in Amplia Therapeutics
Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase inhibitors for oncology and chronic fibrosis in Australia. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. Innate Immunotherapeuti is traded on OTC Exchange in the United States.
Amplia Therapeutics Pink Sheet Technical Analysis
Amplia Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Amplia Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Amplia Therapeutics Limited cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Amplia Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Amplia Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amplia Therapeutics shares will generate the highest return on investment. By undertsting and applying Amplia Therapeutics pink sheet market strength indicators, traders can identify Amplia Therapeutics Limited entry and exit signals to maximize returns
Amplia Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Amplia Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Amplia Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amplia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0394 | |||
| Jensen Alpha | 0.7737 | |||
| Total Risk Alpha | (1.99) | |||
| Sortino Ratio | 0.0273 | |||
| Treynor Ratio | (0.84) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Amplia Pink Sheet analysis
When running Amplia Therapeutics' price analysis, check to measure Amplia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amplia Therapeutics is operating at the current time. Most of Amplia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amplia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amplia Therapeutics' price. Additionally, you may evaluate how the addition of Amplia Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |